Xi Jinping’s entrenched authority within the Chinese Communist Party, reinforced by the absence of term limits and systematic personnel purges, underpins the near-certain trader consensus against his removal before 2027. At 73, he continues to lead key foreign engagements and domestic directives while preparing for the 21st Party Congress in late 2027, where analysts widely anticipate endorsement of a fourth term extending his tenure. Recent health speculation tied to his September 2026 BRICS and U.S. trips has not altered his public schedule or triggered visible elite challenges, consistent with the opacity of succession norms and the sidelining of potential rivals. The implied probability reflects this stability, though abrupt health deterioration, an unforeseen internal crisis, or a major diplomatic reversal could still shift dynamics within the narrow remaining window.